Purespring Therapeutics
Andrew is a Senior Research Commercialisation Manager at the University of Bristol. He works with academic colleagues from the University’s Faculty of Health Sciences to facilitate the translation and commercialisation of a range of technologies and healthcare interventions.
This includes licensing and new company creation. Andrew has 20 years’ experience in Technology Transfer roles and is an experienced non-executive director who currently serves on the board of a number of therapeutic, medical device and public health focused spin-out companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Purespring Therapeutics
1 followers
Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.